-Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition

Press/Media

Period5 Nov 2021

Media coverage

1

Media coverage

  • Title-Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date5/11/21
    PersonsSundar Jagannath
View all 1
View less